Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Meridian Bioscience Inc (VIVO)  
$33.97 0.00 (0.00%) as of 4:30 Thu 1/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 43,750,000
Market Cap: 1.49(B)
Last Volume: 2,039,919 Avg Vol: 2,332,630
52 Week Range: $33.97 - $33.97
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:

    S&P COMPOSITE 1500     NASDAQ COMPOSITE
    S&P SMALLCAP 600     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Meridian Bioscience is a life science company with principal businesses in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, Polymerase Chain Reaction master mixes, and bioresearch reagents used by other diagnostic test manufacturers and researchers in immunological and molecular tests for human, animal, plant and environmental applications. Co.'s reportable segments are: Diagnostics, which includes diagnostic tests and transport media; and Life Science.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 139,603
Total Sell Value $0 $0 $0 $4,198,754
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 4
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 894
  Page 11 of 36  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Phillips David Director   •       •      –    2016-07-22 4 OE $18.07 $135,555 D/D 7,500 12,500     -
   Ellingwood Dwight E Director   •       •      –    2016-06-13 4 OE $17.34 $52,020 D/D 3,000 5,980     -
   Rolih Susan EVP, Reg & Quality Systems   •       •      –    2016-06-02 4 A $0.00 $0 D/D 225 140,969     -
   Ellingwood Dwight E Director   •       •      –    2016-05-16 4 B $19.06 $629 D/D 33 3,174 2.31     -
   Sazdanoff Catherine Director   •       •      –    2016-04-29 4 B $19.20 $147,844 D/D 7,700 7,700 2.39     -
   Baldini Lawrence EVP, Pres Global Operations   •       •      –    2016-04-19 4 A $0.00 $0 D/D 225 90,601     -
   Winslow Amy EVP, Pres & CEO of Magellan   •       •      –    2016-03-24 4 A $0.00 $0 D/D 10,000 10,000     -
   Ellingwood Dwight E Director   •       •      –    2016-02-12 4 B $19.62 $628 D/D 32 3,141 2.31     -
   Phillips David Director   •       •      –    2016-01-22 4 GA $0.00 $0 I/I 5,214 25,626     -
   Phillips David Director   •       •      –    2016-01-22 4 GD $0.00 $0 D/D 5,214 5,000     -
   Phillips David Director   •       •      –    2016-01-07 4 OE $15.73 $82,001 D/D 5,214 10,214     -
   Elagin Vecheslav A EVP, Research & Development   •       •      –    2015-12-09 4 S $19.75 $148,125 D/D (7,500) 54,459     -
   Eberly Richard EVP,Pres Meridian Life Science   •       •      –    2015-12-01 4 S $19.61 $96,740 D/D (4,934) 46,219     -
   Ellingwood Dwight E Director   •       •      –    2015-11-23 4 B $19.27 $617 D/D 32 3,109 2.31     -
   Calzavara Marco G. Pres & Managing Director, MBE   •       •      –    2015-11-10 4 D $20.11 $73,152 D/D (3,637) 54,063     -
   Elagin Vecheslav A EVP, Research & Development   •       •      –    2015-11-10 4 D $20.11 $120,016 D/D (5,967) 61,959     -
   Lueke Melissa Exec VP, CFO   •       •      –    2015-11-10 4 D $20.11 $68,566 D/D (3,409) 156,489     -
   Baldini Lawrence Exec VP, Operations & IS   •       •      –    2015-11-10 4 D $20.11 $51,450 D/D (2,558) 90,376     -
   Rolih Susan EVP, Reg & Quality Systems   •       •      –    2015-11-10 4 D $20.11 $51,289 D/D (2,550) 140,744     -
   Kraeutler John A Chairman and CEO   •       •      –    2015-11-10 4 D $20.11 $69,411 D/D (3,451) 311,683     -
   Eberly Richard EVP,Pres Meridian Life Science   •       •      –    2015-11-10 4 D $20.11 $51,611 D/D (2,566) 51,153     -
   Kraeutler John A Chairman and CEO   •       •      –    2015-11-09 4 D $20.27 $174,869 D/D (8,627) 315,134     -
   Mcilwraith John Director   •       •      –    2015-11-06 4 B $20.19 $20,187 D/D 1,000 2,000 2.39     -
   Kraeutler John A Chairman and CEO   •       •      –    2015-11-06 4 D $19.95 $314,135 D/D (15,750) 323,761     -
   Kraeutler John A Chairman and CEO   •       •      –    2015-11-06 4 OE $14.01 $220,610 D/D 15,750 339,511     -

  894 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 11 of 36
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed